TFRC and cancer: It is notable that oncogenic RAS-harboring cancer cells (such as HT1080) display increased iron content relative to their normal cell counterparts due to an upregulation of transferrin receptor 1 and downregulation of ferritin heavy chain 1 and ferritin light chain [38].